UA91960C2 - Liquid pharmaceutical formulations of fsh and lh - Google Patents

Liquid pharmaceutical formulations of fsh and lh

Info

Publication number
UA91960C2
UA91960C2 UAA200509209A UA2005009209A UA91960C2 UA 91960 C2 UA91960 C2 UA 91960C2 UA A200509209 A UAA200509209 A UA A200509209A UA 2005009209 A UA2005009209 A UA 2005009209A UA 91960 C2 UA91960 C2 UA 91960C2
Authority
UA
Ukraine
Prior art keywords
fsh
pharmaceutical formulations
pluronic
liquid pharmaceutical
formulations
Prior art date
Application number
UAA200509209A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Фабрицио Самаритани
Пьерджорджо Донате
Original Assignee
Эйрес Трейдинг С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эйрес Трейдинг С.А. filed Critical Эйрес Трейдинг С.А.
Publication of UA91960C2 publication Critical patent/UA91960C2/en

Links

Abstract

The invention relates to the field of pharmaceutical formulations of follicle -stimulating hormone (FSH), luteinising hormone (LH), and mixtures of FSH and luteinising hormone (LH), and to methods of producing such formulations. The invention provides a liquid or freeze-dried formulation of FSH, or LH, or FSH and LH comprising a surfactant selected from Pluronic ® F77, Pluronic F87, Pluronic F88 and Pluronic F68.
UAA200509209A 2003-04-02 2004-04-02 Liquid pharmaceutical formulations of fsh and lh UA91960C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03100882 2003-04-02

Publications (1)

Publication Number Publication Date
UA91960C2 true UA91960C2 (en) 2010-09-27

Family

ID=36806115

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200509209A UA91960C2 (en) 2003-04-02 2004-04-02 Liquid pharmaceutical formulations of fsh and lh

Country Status (4)

Country Link
CN (1) CN100488566C (en)
ES (1) ES2358330T5 (en)
UA (1) UA91960C2 (en)
ZA (1) ZA200507287B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102309745B (en) * 2008-09-17 2013-05-08 上海天伟生物制药有限公司 Glycoprotein composition which almost does not contain subunit
CN101347613B (en) * 2008-09-17 2011-10-26 上海天伟生物制药有限公司 Composition of glucoprotein containing nearly no subunit and preparation method thereof
WO2010052879A1 (en) * 2008-11-04 2010-05-14 あすか製薬株式会社 Aqueous composition containing follicle-stimulating hormone
CN102293756A (en) * 2011-08-24 2011-12-28 蚌埠丰原涂山制药有限公司 Freeze-dried powder injection of menotropins and preparation method thereof
CN104856951A (en) * 2015-05-06 2015-08-26 华侨大学 Follicle stimulating hormone transdermal nanometer emulsion and preparation method thereof
CN111686079A (en) * 2019-11-28 2020-09-22 成都泽研生物技术有限公司 Follicle stimulating hormone freeze-dried preparation and preparation method and application thereof
CN115429751B (en) * 2022-09-21 2023-11-17 景泽生物医药(合肥)股份有限公司 Human recombinant follicle-stimulating hormone injection and preparation method thereof

Also Published As

Publication number Publication date
ES2358330T5 (en) 2018-12-03
ZA200507287B (en) 2007-03-28
CN100488566C (en) 2009-05-20
CN1795012A (en) 2006-06-28
ES2358330T3 (en) 2011-05-09

Similar Documents

Publication Publication Date Title
RS20050737A (en) Liquid pharmaceutical formulations fish and lh together with a non- ionic surfactant
WO2004026231A3 (en) Formulation for lipophilic agents
GB0100758D0 (en) Immunogenic complex method of preparation thereof and pharmaceutical compositions containing the same, useful for disease control
MXPA04001524A (en) Rapamycin 29-enols.
WO2002070438A3 (en) Compositions for delivering bisphosphonates
WO2003002136A3 (en) Stable formulation of modified glp-1
MXPA04001523A (en) Rapamycin dialdehydes.
WO2006055511A3 (en) Stable tablet formulation of tetrahydrobiopterin
WO2003026487A3 (en) Medical retrieval device
MXPA03006775A (en) Pharmaceutical formulation.
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
WO2002085311A3 (en) Hcg formulation
UA91960C2 (en) Liquid pharmaceutical formulations of fsh and lh
WO2005007117A3 (en) Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
AU2003255820A1 (en) Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
MXPA03007635A (en) P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same.
CA2453646A1 (en) 5-cnac as oral delivery agent for parathyroid hormone fragments
WO2004066983A3 (en) Controlled release of highly soluble agents
HK1067865A1 (en) Use of hcg and lh in controlled ovarian hyperstimulation
MY144814A (en) Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
TH112701B (en) FSH and LH pharmaceutical formulations.
IL149899A0 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING BUPROPION HCl AS ACTIVE SUBSTANCE
WO2007054151A3 (en) Use of chorionic gonadotropin as an immunosuppressor